Casey Carleton, a patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center. http://bit.ly/khHJA7
Questions about Targeted Therapy Promising For Cancer Patients
Want more info about Targeted Therapy Promising For Cancer Patients?
Get free advice from education experts and Noodle community members.